Abiraterone - Usual
IND 178620 Commercial
Phase 3 small_molecule active
Quick answer
Abiraterone - Usual for Prostate Cancer is a Phase 3 program (small_molecule) at Design Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Design Therapeutics
- Indication
- Prostate Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active